Director, US Medical Affairs, Patient Access and Quality of Care (PAQ) Portfolio Strategy

Director, Us Medical Affairs, Patient Access And Quality Of Care (PAQ) Portfolio Strategy

Gilead Sciences, Inc. is a research-based biopharmaceutical company founded in 1987. Together we deliver life-saving therapies to patients in need. With the commitment and drive you bring to the workplace every day, you will be part of a team that is changing the world and helping millions of people live healthier, more fulfilling lives. Our worldwide staff is a close community where you can see the tangible results of your contributions, where every individual matters, and everyone has a chance to enhance their skills through ongoing development.

Our scientific focus has resulted in marketed products that are benefiting hundreds of thousands of people, a pipeline of late-stage drug candidates, and unmatched patient access programs to ensure medications are available to those who could otherwise not afford them. By joining Gilead, you will further our mission to address unmet medical needs and improve life by advancing the care of patients with life-threatening diseases.

We have an exciting opportunity within US Medical Affairs for a Director, Portfolio Strategy in our Patient Access and Quality of Care (PAQ) team. This role is office-based in our Foster City, CA headquarters, or Parsippany, NJ office.

The role will be part of the PAQ-Portfolio Strategy team and will have responsibility for the delivery of elements of the US Evidence Strategy across the full Gilead portfolio (currently Oncology and Virology). This position will report to the Senior Director, Portfolio Strategy.

Job Responsibilities (including, but not limited to) :

• Contribute to the activities of the USMA PAQ Portfolio Strategy team across the portfolio of medicines in Virology and Oncology
• Assist the Portfolio Strategy team in defining the over-arching portfolio evidence strategy and driving consistency across the US portfolio
• Co-ordinate the US Local Review Committee (LRC) prepare study teams to come to LRC with appropriate, in scope studies and have a robust discussion
• Ensure LRC materials accurately prepared in advance with all the necessary documentation and alignment with other functions in Gilead such as Patient Safety
• Own the reporting for LRC, including tracking studies and publications
• Represent the US LRC needs in relevant global forums with GMA / MAR
• Co-ordinate US Integrated Evidence Strategy (IES) meetings across the portfolio, including preparing cross functional teams
• Deliver tracking of outcomes of US IES meetings with Global evidence generation functions including inclusion in product IEPs, publications and utilization by field teams
• Own initiatives to systematize and deliver access to existing evidence to US teams
• Deliver narrative workshops for priority brands across the portfolio, working with cross-functional US teams to assess potential narratives for medicines and identify evidence generation that would be needed to support
• Collaborate with key cross-functional partners within the US including USMA, US Commercial, US Market Access, Government Affairs and Policy
• Collaborate with Global evidence generation partners GMA / MAR, RWE, HEOR, Clinical Development, Global Publications, PSTs as needed
• Facilitate sharing of best practices and learnings for research across the various USMA teams, heightening collaboration with an attention to speed.

Experience

Display of Gilead Core Values